Burning Rock Biotech Files 6-K Report
Ticker: BNR · Form: 6-K · Filed: Sep 6, 2024 · CIK: 1792267
Sentiment: neutral
Topics: reporting, foreign-private-issuer
Related Tickers: BNR
TL;DR
Burning Rock Biotech (BNR) filed a 6-K, standard reporting for foreign issuers.
AI Summary
Burning Rock Biotech Limited filed a Form 6-K on September 6, 2024. This report is for the month of September 2024 and is filed by a foreign private issuer. The company is incorporated in the People's Republic of China and its principal executive offices are located in Guangzhou, Guangdong.
Why It Matters
This filing indicates ongoing reporting requirements for Burning Rock Biotech as a foreign private issuer, providing transparency to investors.
Risk Assessment
Risk Level: low — A Form 6-K is a routine filing for foreign private issuers and does not typically contain material non-public information that would significantly alter risk.
Key Players & Entities
- Burning Rock Biotech Limited (company) — Registrant
- 001-39316 (other) — Commission File Number
- 20240906 (date) — Filing Date
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the filer?
The filer is Burning Rock Biotech Limited.
When was this report filed?
The report was filed on September 6, 2024.
What is the company's principal executive office location?
The principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
Does the company file annual reports under Form 20-F or 40-F?
The registrant indicates it files annual reports under Form 20-F.
Filing Stats: 284 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-09-06 06:16:28
Filing Documents
- d829109d6k.htm (6-K) — 10KB
- 0001193125-24-214669.txt ( ) — 11KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer Date: September 6, 2024 4